Fredrik Levander

Cancer proteomics group

Molecular profiling of cancers using omics technology can be used for classification, biomarker discovery and enabling of precision cancer treatment. We focus on large scale profiling of proteins, proteomics, and develop methods to get the most possible out of the data.

Our research aims at utilising omics data, with emphasis on proteomics data, to understand complex biology and ultimately guide treatment of cancers. We are collaborating with researchers in projects concerning breast and ovarian cancers and employ proteomics to analyse model systems and clinical specimens.

Proteomics technology is evolving rapidly, enabling comprehensive analysis of post-translational modifications and proteoforms. We are working on new data analysis strategies to get the most possible out of the data and to elucidate functions of different cells in complex samples. We are also interested in combining single-cell and spatial analyses with bulk analyses of tissue to resolve complexity.

Our team has developed several standalone software tools that are available for download:

List of tools at quantitativeproteomics.org

We are always interested in research collaborations in different biological domains.

Group of smiling researchers in a corridor. Photo. — The Cancer proteomics group. Photo: Andreas Hasselgren

Principal Investigator